263 related articles for article (PubMed ID: 32109622)
21. Efficacy of antifungal PACT in an in vitro model of onychomycosis.
Mehra T; Schaller M; Walker B; Braunsdorf C; Mailänder-Sanchez D; Schynowski F; Hahn R; Röcken M; Köberle M; Borelli C
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):86-90. PubMed ID: 24661404
[TBL] [Abstract][Full Text] [Related]
22. Distal and lateral toenail onychomycosis caused by Trichophyton rubrum: treatment with photodynamic therapy based on methylene blue dye.
Souza LW; Souza SV; Botelho AC
An Bras Dermatol; 2014; 89(1):184-6. PubMed ID: 24626676
[TBL] [Abstract][Full Text] [Related]
23. Emerging topical onychomycosis therapies - quo vadis?
Elkeeb R; Hui X; Murthy N; Maibach HI
Expert Opin Emerg Drugs; 2014 Dec; 19(4):489-95. PubMed ID: 25401504
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
Elewski BE; Aly R; Baldwin SL; González Soto RF; Rich P; Weisfeld M; Wiltz H; Zane LT; Pollak R
J Am Acad Dermatol; 2015 Jul; 73(1):62-9. PubMed ID: 25956661
[TBL] [Abstract][Full Text] [Related]
25. Tavaborole (AN-2690) for the treatment of onychomycosis of the toenail in adults.
Gupta AK; Daigle D
Expert Rev Anti Infect Ther; 2014 Jul; 12(7):735-42. PubMed ID: 24894552
[TBL] [Abstract][Full Text] [Related]
26. The dermatopharmacologic profile of ciclopirox 8% nail lacquer.
Bohn M; Kraemer K
J Am Podiatr Med Assoc; 2000; 90(10):491-4. PubMed ID: 11107709
[TBL] [Abstract][Full Text] [Related]
27. Tavaborole 5% Solution: A Novel Topical Treatment for Toenail Onychomycosis.
Gupta G; Foley KA; Gupta AK
Skin Therapy Lett; 2015 Nov; 20(6):6-9. PubMed ID: 27224843
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail.
Rich P; Scher RK; Breneman D; Savin RC; Feingold DS; Konnikov N; Shupack JL; Pinnell S; Levine N; Lowe NJ; Aly R; Odom RB; Greer DL; Morman MR; Bucko AD; Tschen EH; Elewski BE; Smith EB; Hilbert J
J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S103-9. PubMed ID: 9631992
[TBL] [Abstract][Full Text] [Related]
29. Methylene blue vs methyl aminolevulinate photodynamic therapy in the treatment of mild-to-moderate toenail onychomycosis: Short- and medium-term effects.
Alberdi E; Gómez C
Dermatol Ther; 2020 Nov; 33(6):e14280. PubMed ID: 32890444
[TBL] [Abstract][Full Text] [Related]
30. Trichophytum rubrum endonyx onychomycosis resistant to standard oral and topical therapies.
Mulvaney PM; Telang GH; Jellinek N
Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437286
[TBL] [Abstract][Full Text] [Related]
31. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
Pollak RA
J Am Podiatr Med Assoc; 2014 Nov; 104(6):568-73. PubMed ID: 25514267
[TBL] [Abstract][Full Text] [Related]
32. Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis.
Figueiredo Souza LW; Souza SV; Botelho AC
Dermatol Ther; 2014; 27(1):43-7. PubMed ID: 24502311
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the US.
Lipner SR; Joseph WS; Vlahovic TC; Scher RK; Rich P; Ghannoum M; Daniel CR; Elewski B
J Drugs Dermatol; 2021 Oct; 20(10):1076-1084. PubMed ID: 34636509
[TBL] [Abstract][Full Text] [Related]
34. Nail and Foot Procedures.
Bailey J
Prim Care; 2022 Mar; 49(1):63-83. PubMed ID: 35125159
[TBL] [Abstract][Full Text] [Related]
35. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Gupta AK; Konnikov N; Lynde CW
J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
[TBL] [Abstract][Full Text] [Related]
36. Tavaborole - a treatment for onychomycosis of the toenails.
Gupta AK; Versteeg SG
Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1145-52. PubMed ID: 27347905
[TBL] [Abstract][Full Text] [Related]
37. 1,064-nm diode laser therapy of onychomycosis: results of a prospective open treatment of 82 toenails.
Renner R; Grüsser K; Sticherling M
Dermatology; 2015; 230(2):128-34. PubMed ID: 25662740
[TBL] [Abstract][Full Text] [Related]
38. A review of lasers and light for the treatment of onychomycosis.
Ortiz AE; Avram MM; Wanner MA
Lasers Surg Med; 2014 Feb; 46(2):117-24. PubMed ID: 24375507
[TBL] [Abstract][Full Text] [Related]
39. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.
Scher RK; Breneman D; Rich P; Savin RC; Feingold DS; Konnikov N; Shupack JL; Pinnell S; Levine N; Lowe NJ; Aly R; Odom RB; Greer DL; Morman MR; Bucko AD; Tschen EH; Elewski BE; Smith EB
J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S77-86. PubMed ID: 9631989
[TBL] [Abstract][Full Text] [Related]
40. Efinaconazole solution 10% for treatment of toenail onychomycosis in Latino patients.
Cook-Bolden FE; Lin T
Cutis; 2017 Apr; 99(4):286-289. PubMed ID: 28492600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
